666

CALIWAY BIOPHARMACEUTICALS CO LTD

No trades
See on Supercharts

Price target

707.500.000.00%
The 2 analysts offering 1 year price forecasts for 6919 have a max estimate of — and a min estimate of —.

Analyst rating

Based on 2 analysts giving stock ratings to 6919 in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


6919 EPS for the last quarter is −1.32 TWD despite the estimation of −1.31 TWD. In the next quarter EPS is expected to reach −1.31 TWD. Track more of CALIWAY BIOPHARMACEUTICALS CO LTD financials and stay on top of what is up with the company.
In the next quarter CALIWAY BIOPHARMACEUTICALS CO LTD revenue is expected to reach ‪12.50 M‬ TWD. Check out CALIWAY BIOPHARMACEUTICALS CO LTD revenue and earnings and make informed decisions.
According to analysts, 6919 price target is 707.50 TWD with a max estimate of 735.00 TWD and a min estimate of 680.00 TWD. Check if this forecast comes true in a year, meanwhile watch CALIWAY BIOPHARMACEUTICALS CO LTD stock price chart and keep track of the current situation with 6919 news and stock market news.